Loading articles...

Canada reportedly in talks about donating extra doses of COVID-19 vaccines to third-world countries

Last Updated Nov 19, 2020 at 10:11 am EST

FILE - In this Thursday, April 23, 2020 file screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England. A key researcher at the University of Oxford says scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas. Dr. Andrew Pollard, an expert in pediatric infection and immunity at Oxford, said ThursdayNov. 19, 2020 that research was slowed by low infection rates over the summer but the Phase III trials are now accumulating the data needed to report results. (Oxford University Pool via AP, File)

Canada is reportedly in talks with other governments in potential plans to donate extra doses of COVID-19 vaccines to lower-income countries.

The Duke Global Health Innovation Center said Canada has made deals to buy more vaccine doses per capita than any other nation, reserving enough shots to vaccinate the entire population several times over.

A source in Ottawa tells Reuters, the government plans to donate any extra doses through a facility backed by the World Health Organization, which would distribute them among recipient countries.

But, a procurement official said it’s still too early to plan, because it’s not clear if all seven of the suppliers whose shots the government reserved will be approved.

RELATED: Christine Elliott says Canada to receive millions of Pfizer, Moderna COVID-19 vaccines by January

So far, Canada has received developments from two vaccine developers, and now, potentially emerging is a third.

Phase two trials of AstraZeneca’s experimental vaccine shows it appears to work safely in older people, and generates as strong an immune response in those over the age of 70, as it does in younger people.

It’s not clear if the shot protects people from getting sick with COVID-19 — but the trial does show, it generates an immune response that would be expected to provide protection.

The AstraZeneca and Oxford University vaccine is now in phase three clinical trials around the world.

The phase two findings are in the Lancet Medical Journal.

Latest Traffic & Weather
680 NEWS TRAFFIC @680NEWStraffic 680 News Traffic Twitter verified icon
Updated Just moments ago
CLEARED: EB QEW approaching Hurontario. #EBQEW
Latest Traffic
680 NEWS WEATHER @680NEWSweather 
Updated Today at 05:42 PM
Seeing rain and flurries on the weather radar. What are you seeing in your area? #Brampton #Mississauga #Toronto…
Latest Weather